Remember my username
Sign up now
Clinical Pharmacology Unit Review
Institutional Biosafety Committee
EDUCATION and CONSULTING
WIRB Statement of Compliance
Western Institutional Review Board (WIRB) is duly constituted, has written procedures for initial and continuing review of clinical trials; prepares written minutes of convened meetings, and retains records pertaining to the review and approval process; all in compliance with requirements of FDA regulations 21 CFR Parts 50 and 56, HHS regulations 45 CFR 46, and International Conference on Harmonisation (ICH) E6, Good Clinical Practice (GCP), as applicable. WIRB is registered with OHRP/FDA; our IRB registration number is IRB00000533, parent organization number is IORG0000432.
WIRB also reviews in compliance with other applicable federal and state laws and regulations governing IRBs and research with human beings. Where appropriate, WIRB complies with additional regulations and guidelines (such as the Canadian Tri-Council Policy Statement, Ethical Conduct for Research Involving Humans) as required in specific research jurisdictions.
Since 2003, WIRB has been fully accredited by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
If you have questions or need further information, please do not hesitate to contact us.
You may download a copy of this information on WIRB letterhead below:
Use of electronic signatures
WIRB’s electronically signed regulatory documents are generated in compliance with 21 CFR Part 11 regulations regarding electronic records and electronic signatures.
Electronic signatures are available for use in the signature module of the Western Institutional Review Board (WIRB) electronic workflow system. Security rights to access this module are given only to those with signature authority, as listed on the Panel membership rosters.
All signers must attest to an understanding that electronic signatures are the legal equivalent of handwritten signatures prior to attaining signature security rights.
A signer must enter a unique user name and password to access the electronic workflow system. The signer must re-enter his or her own unique password to access the signature module and affix the electronic signature.
An electronic signature can only be applied by the user named in the signature. Proxy signatures—i.e., Dr. X signing for Dr. Y—are clearly indicated on the signed document. Sharing of passwords is prohibited. Changes to records in the system, including all document signings, are recorded in a secure, electronically generated audit trail.
Board Member Documents
Track a Submission